Intraarticular Steroids, Saline and Occupational Therapy in People With CMC1 Osteoarthritis

Exclusion Criteria

• •Use of thumb orthosis on most of the days or structured hand exercises in the last 12 weeks
• •Intraarticular injections in the target CMC-1 joint in the last 12 weeks
• •More than 3 previous IACS in the target CMC-1 joint
• •Use of oral, intramuscular or intravenous steroids in the last 12 weeks
• •Previous surgery of the target CMC-1 joint
• •Planned hand surgery in the coming 24 weeks
• •Do not want to quit using oral or topical NSAIDs on the hands (such as ibuprofen, diclofenac, etoricoxib, naproxen) in the next 12 weeks
• •Systemic inflammatory joint diseases (such as rheumatoid arthritis (RA), psoriatic arthritis or gout) or other conditions that can better explain the hand pain (such as thoracic outlet syndrome, carpal tunnel disease, diabetic cheiropathy, hand injury in previous six months, or palmar tenosynovitis/trigger finger)
• •Diagnosis of fibromyalgia
• •Diagnosis of psoriasis
• •Infection, skin disease or wounds at joint injection site
• •Serious comorbidities, cognitive dysfunction, substance/alcohol abuse or any other medical condition that makes adherence to the study protocol difficult
• •Severe or uncontrolled infections
• •Known hypersensitivity to Triamcinolone acetonide (Kenacort) or any of the excipients (sodium carboxymethylcellulose, sodium chloride, polysorbate, benzyl alcohol, sodium hydroxide or hydrochloric acid)
• •Included in another clinical study
• •Use of digitalis glycosides
• •Patients vaccinated or immunized with live virus vaccines in the last 2 weeks
• •Not being able to talk or understand Norwegian
• •Known pregnancy or planned pregnancy in the next 6 months
• •Any condition that in the view of the investigator would suggest that the patient is unable to comply with the study protocol and procedures